Renato Torre

Prof. Renato Torre

European Laboratory for Non-Linear Spectroscopy and Department of Physics and Astronomy, University of Firenze Via Carrara 1, Sesto Fiorentino 50019, Firenze, Italy
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2019 in The European Physical Journal Special Topics
Verified
Journal Article
Open access
PDF file
AAA. Abada
A. Abada
MAM. Abbrescia
M. Abbrescia
SAS. S. AbdusSalam
S. S. AbdusSalam
IAI. Abdyukhanov
I. Abdyukhanov
JFJ. Abelleira Fernandez
J. Abelleira Fernandez
JZJ. Zurita
J. Zurita
In response to the 2013 Update of the European Strategy for Particle Physics (EPPSU), the Future Circular Collider (FCC) study was launched as a world-wide international collaboration hosted by...

1 July 2015 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
CVCinta Valls-Pedret
Cinta Valls-Pedret
ASAleix Sala-Vila
Aleix Sala-Vila
MSMercè Serra-Mir
Mercè Serra-Mir
DCDolores Corella
Dolores Corella
Renato TorreRenato Torre
Renato Torre
EREmilio Ros
Emilio Ros
Increased lifespan in developed countries has resulted in a greatly increased frequency of age-related diseases, including Alzheimer disease,1 the most common type of dementia.2 The economic and social burden of caring for persons with dementia is increasing, and to date there are no effective pharmacologic agents to prevent or treat the disease3 or even its precursor stages.4 The view is emerging that to achieve a benefit an intervention would likely need to be started in the preclinical stage, a situation that applies to a substantial proportion of the elderly population worldwide.5 Hence, identifying simple and effective interventions to prevent dementia or delay its onset is a major public health priority.

5 September 2006 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
MCMaría-Isabel Covas
María-Isabel Covas
KNKristiina Nyyssönen
Kristiina Nyyssönen
HPHenrik Enghusen Poulsen
Henrik Enghusen Poulsen
JKJari Kaikkonen
Jari Kaikkonen
HZHans-Joachim F. Zunft
Hans-Joachim F. Zunft
FGfor the EUROLIVE Study Group
for the EUROLIVE Study Group
Virgin olive oils are richer in phenolic content than refined olive oil. Small, randomized, crossover, controlled trials on the antioxidant effect of phenolic compounds from real-life daily doses of olive oil in humans have yielded conflicting results. Little information is available on the effect of the phenolic compounds of olive oil on plasma lipid levels. No international study with a large sample size has been done. To evaluate whether the phenolic content of olive oil further benefits plasma lipid levels and lipid oxidative damage compared with monounsaturated acid content. Randomized, crossover, controlled trial. 6 research centers from 5 European countries. 200 healthy male volunteers. Glucose levels, plasma lipid levels, oxidative damage to lipid levels, and endogenous and exogenous antioxidants at baseline and before and after each intervention. In a crossover study, participants were randomly assigned to 3 sequences of daily administration of 25 mL of 3 olive oils. Olive oils had low (2.7 mg/kg of olive oil), medium (164 mg/kg), or high (366 mg/kg) phenolic content but were otherwise similar. Intervention periods were 3 weeks preceded by 2-week washout periods. A linear increase in high-density lipoprotein (HDL) cholesterol levels was observed for low-, medium-, and high-polyphenol olive oil: mean change, 0.025 mmol/L (95% CI, 0.003 to 0.05 mmol/L), 0.032 mmol/L (CI, 0.005 to 0.05 mmol/L), and 0.045 mmol/L (CI, 0.02 to 0.06 mmol/L), respectively. Total cholesterol–HDL cholesterol ratio decreased linearly with the phenolic content of the olive oil. Triglyceride levels decreased by an average of 0.05 mmol/L for all olive oils. Oxidative stress markers decreased linearly with increasing phenolic content. Mean changes for oxidized low-density lipoprotein levels were 1.21 U/L (CI, −0.8 to 3.6 U/L), −1.48 U/L (−3.6 to 0.6 U/L), and −3.21 U/L (−5.1 to −0.8 U/L) for the low-, medium-, and high-polyphenol olive oil, respectively. The olive oil may have interacted with other dietary components, participants' dietary intake was self-reported, and the intervention periods were short. Olive oil is more than a monounsaturated fat. Its phenolic content can also provide benefits for plasma lipid levels and oxidative damage. International Standard Randomised Controlled Trial number: ISRCTN09220811.

20 April 2016 in Chemical Reviews
Verified
Journal Article
Closed access
FPFivos Perakis
Fivos Perakis
LMLuigi De Marco
Luigi De Marco
ASAndrey Shalit
Andrey Shalit
FTFujie Tang
Fujie Tang
ZKZachary R. Kann
Zachary R. Kann
YNYuki Nagata
Yuki Nagata

1 May 2010 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
JLJosé López-Miranda
José López-Miranda
CMCarmen Marin
Carmen Marin
EREmilio Ros
Emilio Ros
RCR. De Caterina
R. De Caterina
Lina BadimonLina Badimon
Lina Badimon
NYN. Yiannakouris
N. Yiannakouris

11 June 2007 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
MFMontserrat Fitó
Montserrat Fitó
MGMònica Guxens
Mònica Guxens
DCDolores Corella
Dolores Corella
Guillermo T SáezGuillermo T Sáez
Guillermo T Sáez
RERamón Estruch
Ramón Estruch
FIfor the PREDIMED Study Investigators
for the PREDIMED Study Investigators
Adherence to the traditional Mediterranean diet (TMD) has been associated with a reduction in coronary heart disease (CHD), cancer, and overall mortality.1-3 This protective effect has been attributed, at least in part, to the richness of this diet in antioxidants.1,3 Current evidence indicates oxidative damage as a promoter of pathophysiological changes occurring in oxidative stress–associated diseases, such as CHD, cancer, and neurodegenerative disorders and also in aging.4 Oxidized low-density lipoprotein (oxLDL) level may play a major role in atherosclerosis and cardiovascular disease and is a commonly used marker for oxidative damage.5,6 An oxLDL predictive value for the onset of mobility disability has also been recently reported.7 Adherence to a Mediterranean type diet has been shown to be associated with lower plasma oxLDL level in a cross-sectional study8 and in a linear intervention study in healthy women.9 However, to our knowledge, no randomized controlled intervention studies have assessed the efficacy of the Mediterranean diet on in vivo LDL oxidation.